Vitamin D3 potentiates the antitumorigenic effects of arsenic trioxide in human leukemia (HL-60) cells

Experimental Hematology and Oncology

Volumn 3, Issue 1, 2014, Pages

  Rogers, Christian S ^a   Yedjou, Clement G ^a   Sutton, Dwayne J ^a   Tchounwou, Paul B ^a  

^a JACKSON STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Arsenic trioxide; Cytotoxicity; HL 60 cells; Vitamin D3

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ARSENIC TRIOXIDE; COLECALCIFEROL; LIPOCORTIN 5;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DNA FRAGMENTATION ASSAY; DRUG CYTOTOXICITY; DRUG POTENTIATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA; NUCLEOSOME; PRIORITY JOURNAL;

EID: 84978023697     PISSN: None     EISSN: 21623619     Source Type: Journal    
DOI: 10.1186/2162-3619-3-9     Document Type: Article

References (28)

1. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J, Scheinberg DA, Pandolfi PP, Warrell RP. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 1998, 339:1341-1348. 10.1056/NEJM199811053391901, 9801394.
2. Soignet SL, Frankel SR, Douer D, Tallman MS, Kantarjian H, Calleja E, Stone RM, Kalaycio M, Scheinberg DA, Steinherz P, Sievers EL, Coutré S, Dahlberg S, Ellison R, Warrell RP. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol 2001, 19:3852-3860.
3. Chen GQ, Zhu J, Shi XG, Ni JN, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR/PML proteins. Blood 1996, 88:1052-1061.
4. Rousselot P, Labaume S, Marolleau JP, Larghero J, Noguera MH, Brouet JC, Fermand JP. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients. Cancer Res 1999, 59:1041-1048.
5. Shen L, Chen TX, Wang YP, Lin Z, Zhao HJ, Zu YZ, Wu G, Ying DM. Arsenic trioxide induced apoptosis of the human B lymphoma cell line MBC-1. J Biol Regulat Homeost Agent 2000, 14:116-119.
6. Wang QM, Jones JB, Studzinski GP. Cyclin-dependent kinase Inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res 1996, 56:264.
7. Chen YC, Lin-Shiau SY, Lin JK. Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J Cell Physiol 1998, 177:324-333. 10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9, 9766529.
8. Jing Y, Dai J, Chalmers-Redman RM, Tatton WG, Waxman S. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 1999, 94:2102-2111.
9. Huang HS, Chang WC, Chen CJ. Involvement of reactive oxygen species in arsenite-induced downregulation of phospholipid hydroperoxide glutathione peroxidase in human epidermoid carcinoma A431 cells. Free Radic Biol Med 2002, 33:864-873. 10.1016/S0891-5849(02)00983-8, 12208374.
10. Yedjou CG, Tchounwou PB. In vitro cytotoxic and genotoxic effects of arsenic trioxide on human leukemia (HL-60) cells using the MTT and alkaline single cell gel electrophoresis (comet) assays. Mol Cell Biochem 2007, 301:123-130. 10.1007/s11010-006-9403-4, 3760965, 17216127.
11. Mellanby E. An experimental investigation on rickets. Lancet 1919, 193(4985):407-412.
12. Napoli JL, Fivizzani MA, Schnoes HK, DeLuca HF. Synthesis of vitamin D5: its biological activity relative to D3 and D2. Arch Biochem Biophys 1979, 197:119-125. 10.1016/0003-9861(79)90226-1, 232394.
13. Banach-Petrosky W, Ouyang X, Gao H, Nader K, Ji Y, Suh N, DiPaola RS, Abate-Shen C. Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1;Pten mutant mice. Clin Cancer Res 2006, 12:5895-5901. 10.1158/1078-0432.CCR-06-1039, 17020998.
14. Trump DL, Deeb K, Johnson CS. Vitamin D: Considerations in the continued development as an agent for cancer prevention and therapy. Cancer J 2010, 16(1):1-9. 10.1097/PPO.0b013e3181c51ee6, 2857702, 20164683.
15. Yedjou C, Tchounwou PB, Jenkins J, McMurray R. Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60). J. Hematol Oncol 2010, 3:28. 10.1186/1756-8722-3-28, 2939535, 20796291.
16. Thorne J, Campbell MJ. The vitamin D receptor in cancer. Proc Nutr Soc 2008, 67(2):115-127. 10.1017/S0029665108006964, 18412986.
17. Moreno J, Krishnan AV, Feldman D. Molecular mechanisms mediating the antiproliferative effects of vitamin D in prostate cancer. J Steroid Biochem Mol Biol 2005, 97(1-2):31-36.
18. Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007, 7(9):684-700. 10.1038/nrc2196, 17721433.
19. Tchounwou PB, Yedjou CG, Dorsey WC. Arsenic trioxide induced transcriptional activation and expression of stress genes in human liver carcinoma cells (HepG2). Cellular and Molecular Biology™ 2003, 49(7):1071-1079.
20. Yedjou CG, Thuisseu LD, Tchounwou CK, Gomes M, Howard C, Tchounwou PB. Ascorbic acid potentiation of arsenic trioxide anticancer activity against acute promyelocytic leukemia. Archives of Drug Information 2009, 2(4):59-65. 10.1111/j.1753-5174.2009.00022.x, 2805867, 20098508.
21. Norman AW, Roth J, Orci L. The vitamin D endocrine system: steroid metabolism, hormone receptors and biological response (calcium binding proteins). Endocr Rev 1982, 3:331-366. 10.1210/edrv-3-4-331, 6295752.
22. Henry HL, Norman AW. Vitamin D: metabolism and biological actions. Annu Rev Nutr 1984, 4:493-498. 10.1146/annurev.nu.04.070184.002425, 6087861.
23. Gysemans CA, Cardozo AK, Callewaert H. 1,25- Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. Endocrinology 1956-1964, 2005:146.
24. Abe E, Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T, Yoshiki S, Suda T. Differentiation of mouse myeloid leukemia cells induced by 1,25-dihydroxyvitamin D3. Proceedings of the National Academy of Sciences of the United States of America, Volume 78 1981, 4990-4994.
25. Wyllie AH. Apoptosis and carcinogenesis. Eur J Cell Biol 1997, 73:189.
26. Rudel T, Bokoch GM. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 1997, 276:1571. 10.1126/science.276.5318.1571, 9171063.
27. Dive C, Evans CA, Whetton AD. Induction of apoptosis-new targets for cancer chemotherapy. Semin Cancer Biol 1992, 3:417.
28. Sachs L, Lotem J. Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 1993, 82:15.